Salvage local ablation therapy for radiation-recurrent prostate cancer

JRCT ID: jRCTs052180227

Registered date:30/03/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Prostate cancer
• Date of first enrollment: 29/03/2017
• Target sample size: 5
• Study type: Interventional
• Intervention(s): none

Outcome(s)

Primary Outcome

Biochemical recurrence
Adverse event

• Secondary Outcome: Overall survival

Key inclusion & exclusion criteria

• Age minimum: 20age
• Age maximum: N/A
• Gender: Male

Include criteria

1) Patients with relapsed prostate cancer who have received radiation therapy
2) Patients whose initial clinical stage was T1N0 or T2N0
3) Serum PSA level less than 10ng/ml
4) Age more than 20 years old (at the time of consent for the study)

Exclude criteria

1) Ptients with active urinary tract infection such as cystitis, prostatitis and urethraitis)
2) Patients with prostate cancer who have metastasis
3) Patietns with prostate stone

Related Information

• Primary Sponsor: Ukimura Osamu
• Secondary ID(s): UMIN000035440